Fewer kindergarteners are being vaccinated, CDC data show
Rates dipped to 92.1 percent for the diphtheria, tetanus, and acellular pertussis vaccine (DTaP) and to 92.5 percent for the measles, mumps and rubella vaccine (MMR) and polio vaccine, the data show.
The drop in vaccination coverage comes as the U.S. grapples with rising cases of the measles—one of the most contagious diseases in the world.
There have been 29 outbreaks of the virus this year, resulting in more than 1,330 confirmed measles cases across 40 states, according to the latest CDC numbers.
Herd immunity against measles requires roughly 95 percent of the population to be vaccinated against the disease, according to the World Health Organization.
Vaccine coverage decreased in more than half of states during the last school year compared to the year before, with about 286,000 kindergartners attending school without documentation showing they completed the MMR vaccine series.
Vaccine exemptions for one or more vaccines have also gone up, with a total of 138,000 kindergarteners exempt from a vaccine in the last school year.
The number of exemptions rose to 3.6 percent during the 2024-25 school year from 3.3 percent the year before.
Exemptions increased in 36 states and Washington D.C. with 17 states now reporting an exemption rate of more than 5 percent, the data show.
The Trump administration has shaken up the country's federal vaccine policy, sparking concerns among the medical community about the future of vaccine access.
Health and Human Services Secretary Robert F. Kennedy, who has a long history of vaccine skepticism, has changed the process for vaccine recommendations as well as who is eligible for COVID-19 vaccines.
'The decision to vaccinate is a personal one,' a spokesperson for the Department of Health and Human Services told The Hill. 'Parents should consult their health care providers on options for their families.'
The spokesperson added that vaccination remains the most effective way to protect children from serious diseases like measles and whooping cough which can lead to hospitalization and death.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
25 minutes ago
- New York Post
Trying to lose weight? This common mealtime mistake could be sabotaging your progress
Lifestyle choices impact your weight, but your genes can tip the scales, too. New research suggests that people with a higher risk for obesity may be sabotaging their efforts to slim down by making a simple mealtime mistake. The good news? Scientists found an easy switch that can help fight back against what's written in your DNA — and it's not about changing what's on your plate. Advertisement 3 While lifestyle factors like diet and exercise are crucial, genetics can influence a person's predisposition to weight gain Creativa Images – The study followed nearly 1,200 overweight and obese adults in Spain taking part in a 16-week weight-loss program. About 80% were women, with an average age of 41. Researchers calculated each person's polygenic risk score for body mass index (BMI) — a genetic measure of their obesity risk. Advertisement They also tracked when participants ate, splitting them into 'early' and 'late' eaters based on the midpoint between their first and last meals of the day. After a 12-year follow-up, participants gained 2.2% more body weight for every hour that their meal midpoint was delayed. 3 Eating earlier in the day is linked to better long-term weight loss success, researchers found. ayselucar – The researchers also found a 'significant interaction' between meal timing and genetic risk scores. Advertisement Over the study period, participants with a high genetic predisposition for obesity saw their BMI increase by more than 2 points for every hour they delayed eating. No such link was observed in those with lower genetic risk. People with both a high genetic risk and later meal times had the highest BMI, while early eaters kept theirs lower. 'These findings suggest that early eating may be especially relevant for individuals with a genetic predisposition for obesity and not for others,' the study authors wrote. 3 Projections indicate that the majority of US adults will be overweight or obese by 2050. chathuporn – Advertisement The implications are serious. Across the country, more than 100 million adults have obesity, and over 22 million have severe obesity, according to the Centers for Disease Control and Prevention. This extra weight increases their risk for a wide range of chronic health conditions, including type 2 diabetes, heart disease, stroke, high blood pressure and even some cancers. It also drives up healthcare costs. In 2019, adults with obesity spent an average of $1,861 more per year on medical care than those at a healthy weight. For those with severe obesity, excess costs topped $3,000 per person. Without strong interventions, the problem is only expected to grow worse. While surveys have found that many overweight Americans want to slim down, research shows that conventional methods like calorie restriction often fail to keep the weight off long-term. The study authors said that understanding the link between genetic risk for obesity and meal timing could pave the way for personalized prevention and targeted behavioral interventions in the future. One example they highlighted is precision nutrition, which designs eating plans based on a person's DNA, microbiome, and metabolic responses — moving beyond the one-size-fits-all approach.
The Hill
25 minutes ago
- The Hill
FDA reinstates ousted top vaccine regulator Vinay Prasad
Vinay Prasad, a top vaccine regulator ousted from the Food and Drug Administration (FDA) late last month, is set to return to his post, according to the Department of Health and Human Services (HHS). 'At the FDA's request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,' an HHS spokesperson told The Hill in a statement. 'Neither the White House nor HHS will allow the fake news media to distract from the critical work the FDA is carrying out under the Trump administration.' Prasad's July 30 resignation as the FDA's chief science officer followed criticism from right-wing figures — including activist Laura Loomer and former Sen. Rick Santorum (R-Pa.) — that ran parallel to a regulatory showdown with drug manufacturers over a gene therapy treatment for boys with Duchenne muscular dystrophy. Loomer, a key ally of President Trump with noticeable influence, lavished attacks on the FDA official in recent weeks — calling him a 'saboteur' and 'trojan horse' for HHS's 'Make America Healthy Again' initiative. Prasad was named head of the FDA's Center for Biologics Evaluation and Research in early May as a replacement for Peter Marks, who resigned from the position in March after clashing with HHS Secretary Robert F. Kennedy Jr. The doctor, just one of several health officials tapped by Trump who criticized COVID-19 vaccines, had been in the role for less than three months when the FDA announced he would step down. 'Dr. Prasad did not want to be a distraction to the great work of the FDA in the Trump administration and has decided to return to California and spend more time with his family,' an HHS spokesperson said at the time. 'We thank him for his service and the many important reforms he was able to achieve in his time at FDA.' The division at the time was also involved in a dispute between the administration and Sarepta Therapeutics. The FDA had paused shipments and clinical trials of its Elevidys treatment for those with Duchenne muscular dystrophy following reports of two patients that died after receiving the drug. Prior to his role in the administration, Prasad had argued against the treatment's approval after Marks overrode multiply agency reviews. He also recently made headlines for restricting the approval of two COVID-19 vaccines while disregarding recommendations from government scientists. Two memos issued last month by the FDA showed how the doctor personally intervened to place limitations on drugmakers Novavax and Moderna after their coronavirus shots were approved for anyone 12 years or older.
Fox News
an hour ago
- Fox News
Dr. Marc Siegel explains why chikungunya virus will not lead to global pandemic
Senior medical analyst Dr. Marc Siegel weighs in after the U.S. issued a travel warning in response to the chikungunya virus outbreak in China.
